S.O.S. NALOXONE HYDROCHLORIDE INJECTION DIN 02453258
Health Canada record
| Active ingredient(s) | NALOXONE HYDROCHLORIDE 0.4 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Subcutaneous; Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | V03AB15 NALOXONE |
| Original market date | 21-Jun-2016 |
| Current status date | 21-Jun-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NALOXONE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02555441 | KLOXXADO | HIKMA CANADA LIMITED | Spray (Metered-Dose) | NALOXONE HYDROCHLORIDE 8 MG | Approved |
| 02148706 | NALOXONE HCL INJECTION - 0.4MG/ML USP | SANDOZ CANADA INCORPORATED | Liquid | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed |
| 02148714 | NALOXONE HCL INJECTION - 1MG/ML USP | SANDOZ CANADA INCORPORATED | Liquid | NALOXONE HYDROCHLORIDE 1 MG | Marketed |
| 02548194 | NALOXONE HYDROCHLORIDE INJECTION USP | STERINOVA INC. | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed |
| 02518074 | NALOXONE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Approved |
| 02534975 | NALOXONE HYDROCHLORIDE INJECTION, USP | EUGIA PHARMA INC. | Solution | NALOXONE HYDROCHLORIDE 4 MG | Marketed |
| 02515261 | NALOXONE HYDROCHLORIDE INJECTION, USP | AURO PHARMA INC | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Approved |
| 02515288 | NALOXONE HYDROCHLORIDE INJECTION, USP | AURO PHARMA INC | Solution | NALOXONE HYDROCHLORIDE 4 MG | Approved |
| 02518066 | NALOXONE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Approved |
| 02534967 | NALOXONE HYDROCHLORIDE INJECTION, USP | EUGIA PHARMA INC. | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Approved |
| 02458578 | NALOXONE INJECTABLE | HIKMA CANADA LIMITED | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed |
| 02458179 | NARCAN NASAL SPRAY | EMERGENT OPERATIONS IRELAND LIMITED | Spray (Metered-Dose) | NALOXONE HYDROCHLORIDE 2 MG | Approved |
| 02458187 | NARCAN NASAL SPRAY | EMERGENT OPERATIONS IRELAND LIMITED | Spray (Metered-Dose) | NALOXONE HYDROCHLORIDE 4 MG | Marketed |
| 02511568 | TEVA-NALOXONE NASAL SPRAY | TEVA CANADA LIMITED | Spray (Metered-Dose) | NALOXONE HYDROCHLORIDE 4 MG | Marketed |
| 01913948 | NARCAN INJECTION 0.02MG/ML | BRISTOL-MYERS SQUIBB CANADA | Liquid | NALOXONE HYDROCHLORIDE 0.02 MG | Cancelled Post Market |
| 01913956 | NARCAN INJECTION 0.4MG/ML | BRISTOL-MYERS SQUIBB CANADA | Solution | NALOXONE HYDROCHLORIDE 0.4 MG | Cancelled Post Market |
| 01913964 | NARCAN INJECTION 1MG/ML | BRISTOL-MYERS SQUIBB CANADA | Liquid | NALOXONE HYDROCHLORIDE 1 MG | Cancelled Post Market |
| 02453266 | S.O.S. NALOXONE HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | NALOXONE HYDROCHLORIDE 1 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 17912 | 2016-03-22 | New Drug Submission (NDS) |
International API supply for NALOXONE HYDROCHLORIDE
8 active FDA Drug Master Files.
Request a quote for S.O.S. NALOXONE HYDROCHLORIDE INJECTION